Jul 31, 2020 / 06:00AM GMT
Toshiaki Sai - Daiichi Sankyo Company, Limited - CFO, Executive VP, Head of Corporate Strategy & Management Division and Representative Director
[Interpreted] This is Toshiaki Sai. Thank you very much for attending Daiichi Sankyo's financial results presentation despite your busy schedule. I'd like to provide the following discussion by referring to the document of FY 2020 Q1 financial results announced at 1:00 p.m. today.
Please go to Slide 2. For the content of today's presentation, we will be speaking the topics in the following order: actions against the infectious disease of COVID-19, DS-106 (sic) [DS-1062] strategic collaboration, consolidated financial results from Q1 in FY 2020, FY 2020 forecast and business update.
After these discussions, Wataru Takasaki, who is the Head of R&D division, will provide updates on our R&D. We will take your questions in the end.
Please go to Slide 3. This slide shows updates on our actions against COVID-19. The first part is about vaccine manufacturing and supply. We started discussions with AstraZeneca in June about the
Q1 2021 Daiichi Sankyo Co Ltd Earnings Call Transcript
Jul 31, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers